StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
JYOTHYLAB.NS$199.99+0.30%
Fair $199.99+0.0%

JYOTHYLAB.NS

Jyothy Labs Limited

Consumer Defensive / Household & Personal ProductsNSE

$199.99

+0.60 (+0.30%)

Fairly Valued+0.0%Fair Value $199.99Fund rank 38/100 · Data gapFallback financials|
SA 41/C
F-Score: 4/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 23% · confianza 25%

FCF escenarios

weak_data · normalized FCF $2.9B · quality 80.0/100

Data gap 38/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 79/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

41/100

C

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · JYOTHYLAB.NSLocal privado en este navegador · Jyothy Labs Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$73.4B

P/E

21.5x

↑

EV/EBITDA

13.3x

↑

ROE

18.1%

↑

Gross Margin

49.5%

↑

Debt/Equity

0.03

↓
52-Week Range$200
$196$365

TradingView lightweight chart

JYOTHYLAB.NS price, volumen y niveles de valoración

Último $199.99Periodo +403.7%
Fair value: $199.99

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+9.0%

FCF CAGR

+12.8%

FCF margin

8.9%

FCF / Net income

0.68x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $28.45B · net income $3.70B · FCF $2.53B

2022-FY → 2025-FY

Gross margin

49.5%+8.4% pts

Operating margin

15.7%+6.9% pts

Net margin

13.0%+5.6% pts

FCF margin

8.9%+0.9% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$28.45B$28.45B$27.55B$24.84B$21.95B
Net Income$3.70B$3.70B$3.69B$2.40B$1.62B
EBITDA$5.51B$5.51B$5.34B$3.62B$2.67B
EPS10.0910.0910.066.534.41
Gross Margin49.5%49.5%48.6%41.8%41.1%
Operating Margin15.7%15.7%15.7%10.8%8.8%
Net Margin13.0%13.0%13.4%9.7%7.4%
Balance Sheet
Debt/Equity0.030.030.030.030.12
Current Ratio2.682.68———
Cash Flow
Free Cash Flow$2.53B$2.53B$4.21B$2.93B$1.77B
Returns
ROE18.1%18.1%20.4%15.5%11.2%
Valuation
P/E21.4821.4844.1729.9534.85
EV/EBITDA13.3113.3130.5219.6621.51
P/B3.583.589.024.643.91
Growth & Yield
Revenue Growth3.3%3.3%10.9%13.2%—
EPS Growth0.3%0.3%54.1%48.1%—
Dividend Yield1.8%1.8%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

20.7%

exigente

EPS terminal req.

$17.75

Spread vs growth

-20.4%

5Y implied EPS CAGR

16.3%

exigente

EPS terminal req.

$21.47

Spread vs growth

-16.0%

10Y implied EPS CAGR

13.1%

razonable

EPS terminal req.

$34.58

Spread vs growth

-12.8%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -40.3%

Total return

-40.3%

Start / end P/E

34.3x → 19.8x

EPS bridge

10.06 → 10.09

Residual

-0.1%

EPS growth+0.3%
Multiple rerating-42.3%
Dividend+1.8%
Residual / FX / buybacks / cross-term-0.1%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.